According to Merck's latest financial reports the company has a price-to-book ratio of 8.82.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 7.34 | 20.19% |
2022-12-31 | 6.11 | 20.7% |
2021-12-31 | 5.06 | -37.89% |
2020-12-31 | 8.15 | -8.27% |
2019-12-31 | 8.88 | 20.52% |
2018-12-31 | 7.37 | 66.17% |
2017-12-31 | 4.43 | 10.13% |
2016-12-31 | 4.03 | 22.72% |
2015-12-31 | 3.28 | -0.67% |
2014-12-31 | 3.30 | 17.97% |
2013-12-31 | 2.80 | 25.34% |
2012-12-31 | 2.23 | 10.71% |
2011-12-31 | 2.02 | 3.2% |
2010-12-31 | 1.96 | 5.86% |
2009-12-31 | 1.85 | -39.16% |
2008-12-31 | 3.04 | -50.47% |
2007-12-31 | 6.13 | 29.51% |
2006-12-31 | 4.73 | 39.03% |
2005-12-31 | 3.40 | -5.53% |
2004-12-31 | 3.60 | -31.56% |
2003-12-31 | 5.27 | -4.43% |
2002-12-31 | 5.51 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.13 | -41.85% | ๐บ๐ธ USA |
Novartis NVS | 4.28 | -51.53% | ๐จ๐ญ Switzerland |
Pfizer PFE | 1.61 | -81.77% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 4.80 | -45.62% | ๐บ๐ธ USA |
Eli Lilly LLY | 64.3 | 628.39% | ๐บ๐ธ USA |
Amgen AMGN | 23.2 | 162.91% | ๐บ๐ธ USA |
Sanofi SNY | 1.48 | -83.27% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | 3.10 | -64.82% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 5.15 | -41.66% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | 1.88 | -78.68% | ๐ฎ๐ฑ Israel |